Subscribe to Ophthalmology
View Sample

FREE Email Newsletter

Helping the Blind to Navigate Anywhere

September 20, 2013 10:53 am | by Draper Laboratory | News | Comments

Navigation devices used by blind people today lack the ability to operate indoors and other areas where GPS is not available, and are unable to help the user deal with items that aren’t part of maps, such as crowds and cars. Auburn University is building a prototype device that can address both problems...

FDA Ophthalmic Devices Panel Favorably Votes for the Resure Sealant

September 19, 2013 7:09 pm | by Business Wire | News | Comments

The Food and Drug Administration’s (FDA) Ophthalmic Devices Panel concluded that ReSure Sealant (Ocular Therapeutix, Inc., Bedford, MA), a first-of-a-kind medical device in the United States, is safe and effective for the management of clear corneal wound leaks following cataract surgery.

First Self-Powered Artificial Retina Could Allow Normal Visual Acuity and Restoration of Color Vision

September 17, 2013 9:57 am | by PR Newswire | News | Comments

The U.S. Patent Office has awarded patent no. 8,433,417 to Newcyte Inc. for a carbon nanostructure artificial retinal implant. Newcyte was purchased in 2009 by Natcore Technology Inc. "There are several other patents for artificial retinas," says Dr. Dennis Flood, Natcore's Chief Technology Officer and the inventor of the device. "But all of them have limitations...


Safe Navigation for Visually Impaired Persons

September 10, 2013 9:57 am | by Karlsruhe Institute of Technology | News | Comments

Blind and visually impaired persons find it very difficult to move about in unknown environments. The white canes used by them are still the preferred tools for orientation. The project “A Mobility and Navigational Aid for Visually Impaired Persons” wants to help visually impaired persons to orient themselves in new environments by means of computer-aided vision.

Mobile vision app is looking for a partner after raising $550k

September 3, 2013 7:29 am | by Mass Device | News | Comments

Texas mobile health startup Vital Art & Science is looking for a pharmaceutical industry partner now that it's raised $550,000 in support of its MyVisionTrack iPhone hyperacuity test. MyVisionTrack is an FDA-cleared smartphone app for detecting age-related macular degeneration and other age-related visual impairments.

Coming Soon to an Optometrist's Office Near You: Wavefront Analysis

August 27, 2013 10:19 am | by Wolters Kluwer Health | News | Comments

Techniques developed by astronomers seeking a clear view of objects in space are coming closer to home, as eye care professionals apply the concept of wavefront optics to understanding—and correcting—subtle visual abnormalities of the human eye, according to a special article in the September issue of Optometry and Vision Science...

Time-Release Coating Allows Drug for Macular Degeneration to Last Longer

August 19, 2013 11:12 am | by Johns Hopkins Medicine | News | Comments

Johns Hopkins biomedical engineers have teamed up with clinicians to create a new drug-delivery strategy for a type of central vision loss caused by blood vessel growth at the back of the eye, where such growth should not occur. In addition to testing a new drug that effectively stops such runaway vessel growth in mice, the team gave the drug a biodegradable coating to keep it in the eye longer.

Abbott closes OptiMedica buyout

August 19, 2013 10:52 am | by Mass Device | News | Comments

Abbott said it closed the buyout of OptiMedica Corp. it announced in July, paying $250 million up front with another $150 million on the table if development, regulatory and sales milestones are met. The buyout expands the Chicago-area healthcare giant's Abbott Medical Optics ophthalmology unit by adding femtosecond laser-assisted cataract surgery to its portfolio.


Supercomputers 'Bending' DNA to Prevent Cancer

August 19, 2013 10:19 am | by Lisa-Joy Zgorski, NSF | News | Comments

Understanding how the human body recognizes damaged DNA and initiates repair fascinates Michael Feig, professor of biochemistry and molecular biology at Michigan State University. Feig studies the proteins that recognize defective ...  

STAAR Surgical Gains Regulatory Approval in India for Its Visian@ ICLT with CentraFLOWT

August 19, 2013 6:30 am | by The Associated Press | News | Comments

STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that it has received regulatory approval to market its Visian@ Implantable Collamer@ Lens (ICLT) with CentraFLOWT technology from the CDSCO in India.

Making Connections in the Eye

August 8, 2013 12:06 pm | by Anne Trafton, MIT News Office | News | Comments

The human brain has 100 billion neurons, connected to each other in networks that allow us to interpret the world around us, plan for the future, and control our actions and movements. MIT neuroscientist Sebastian Seung wants to map those networks, creating a wiring diagram of the brain that could help scientists learn how we each become our unique selves.

Bioprinting: From Concept to Reality

August 7, 2013 2:24 pm | by Stephen L. Pentoney Jr., PhD, MBA, and Sharon C. Presnell, PhD, Organovo | Articles | Comments

The field of Tissue Engineering, an interdisciplinary field focused on building or regenerating functional three-dimensional tissues, has deployed several fabrication strategies aimed at bringing cells and structure together to generate tissue.  

Healthcare apps: Autovative Products becomes GlassesOff, merges with Ucansi

August 7, 2013 10:59 am | by Mass Device | News | Comments

In a complex sequence of spin-offs, name-changes and mergers, the dust has settled for vision correction company GlassesOff, formerly called Autovative Products and recently restructured through a merger with software company Ucansi. The former Autovative Products also created a spin-off, Autovative Technologies, which will be headed by former CEO David Funderburk.


Ocular Therapeutix Announces FDA Panel Meeting for the ReSure® Sealant

August 5, 2013 3:11 pm | by Business Wire | News | Comments

Ocular Therapeutix, Inc. announced today that the U.S. Food and Drug Administration (FDA) has scheduled an Ophthalmic Devices Panel meeting on September 19, 2013 to discuss, make recommendations, and vote on the company’s Premarket Approval (PMA) Application for the ReSure Sealant.

Coating Turns Ordinary Glass into Super Glass

August 5, 2013 10:48 am | by Wyss Institute for Biologically Inspired Engineering at Harvard | News | Comments

A new transparent, bioinspired coating makes ordinary glass tough, self-cleaning and incredibly slippery, a team from the Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard School of Engineering and Applied Sciences (SEAS) reported online in the July 31 edition of Nature Communications.

Ocular Therapeutix wins FDA panel date for ReSure sealant

August 2, 2013 2:10 pm | by Mass Device | News | Comments

An FDA advisory panel is slated to convene Sept. 19 to review the pre-market approval application for Ocular Therapeutix Inc.'s ReSure sealant. The FDA's Ophthalmic Devices Panel will review the PMA for the ReSure product, a hydrogel designed to seal incisions to the cornea made during cataract or intraocular lens placement surgery.

New Corrective Vision Technology Eyes Success, but Cost Too High for Market Adoption

August 1, 2013 1:24 pm | by GlobalData | News | Comments

Orthokeratology, also known as corneal refractive therapy, has re-emerged as a treatment for near and far-sightedness, but while the technology provides an intermediate solution between existing interventions, its high price tag will hinder its adoption in the corrective vision market, according to an analyst with research and consulting firm GlobalData.

An App to Lead the Blind

August 1, 2013 10:02 am | by Inderscience Publishers | News | Comments

A smartphone app that keeps track of your location and distance walked from home or hotel and warns you when you are likely to be caught out after dark has been developed by researchers in Pakistan to help sufferers of the debilitating disease night blindness.

Self Powered Contact Lenses for Medical Applications

July 29, 2013 6:33 pm | by PR Newswire | News | Comments

EP Global Communications, Inc. and EPGL Medical announced today that Company engineers have invented the world's first self powered, self contained, power source for contact lenses.  The power supply comes from within the lenses and is self perpetuating day or night. 

ReVision Optics sees $55M funding round

July 29, 2013 12:11 pm | by Mass Device | News | Comments

ReVision Optics said it's raised $55 million from a consortium of investors and closed enrollment in a clinical trial of its Raindrop near vision inlay to treat presbyopia. The Lake Forest, Calif.-based company said all of its existing backers – Canaan Partners, ProQuest Investments, InterWest Partners and Domain Assoc. – were joined by new investors Johnson & Johnson Development Corp. and RusnanoMedInvest in the round.

Second Sight eyes $10M funding round | Wall Street Beat

July 25, 2013 11:39 am | by Mass Device | News | Comments

Second Sight Medical is hoping to raise $10.5 million, according to a regulatory filing, as it brings its "bionic eye" Argus II retinal implant to the U.S. market. The device, comprised of an eyeglass-mounted camera and an electrical stimulator implanted in the eye, works by converting video images captured by a miniature camera housed in the patient's glasses...

Chips that Mimic the Brain

July 23, 2013 10:08 am | by University of Zurich | News | Comments

No computer works as efficiently as the human brain – so much so that building an artificial brain is the goal of many scientists. Neuroinformatics researchers from the University of Zurich and ETH Zurich have now made a breakthrough in this direction by understanding how to configure so-called neuromorphic chips to imitate the brain's information processing abilities in real-time.

Abbott Will Pay $560M to Acquire 2 Med Tech Firms

July 15, 2013 11:45 am | by The Associated Press | News | Comments

Abbott Laboratories announced Monday it would pay a combined $560 million to acquire two privately-held companies focused on coronary implants and laser-assisted eye surgery. The acquisitions of Idev Technologies and OptiMedica Corp will help the health care company expand its medical device offerings.

Abbott to Enter Laser Cataract Surgery Market through Acquisition of OptiMedica

July 15, 2013 8:30 am | by PR Newswire | News | Comments

Abbott has announced it has entered into an agreement to purchase OptiMedica Corporation, a privately held, Silicon Valley-based ophthalmic device company. The acquisition will enable Abbott to expand its vision care business into the femtosecond laser-assisted cataract surgery market.

Mobile Guide for the Blind

July 12, 2013 12:09 pm | by Asociación RUVID | News | Comments

A research group at the University of Alicante has developed an application for smart phones designed for the blind to overcome aerial obstacles such as branches or awnings, which cannot be done with guide dogs or walking sticks. This software has been  awarded a prize by the Vodafone Foundation.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.